The latest financial statement is for the quarter ending 2026-04-04.
| Cash Flow | 2026-04-04 | 2026-01-03 | 2025-09-27 | 2025-06-28 |
|---|---|---|---|---|
| Net income | 41,653 | 178,752 | 14,064 | 32,218 |
| Depreciation and amortization | 3,044 | 2,728 | 2,599 | 5,211 |
| Amortization of deferred debt issuance costs | 965 | 1,009 | 1,493 | 3,350 |
| Reduction in carrying amount of operating lease right of use assets | 4,607 | 4,454 | 4,527 | 8,704 |
| Non-cash share-based compensation | 4,147 | 3,946 | 4,960 | 16,155 |
| (gain) loss on disposal or impairment of licenses, property and equipment, and software | 24 | -1,144 | -402 | -319 |
| Fair value adjustments on interest rate derivatives | -647 | -5,917 | -6,154 | -17,580 |
| Loss on debt extinguishment | - | 0 | -5,862 | - |
| Deferred income taxes | 0 | -143,641 | 0 | 607 |
| Patient accounts receivable | 19,327 | 5,201 | -6,017 | 31,033 |
| Prepaid expenses | 2,857 | -924 | -4,064 | -1,490 |
| Other current and long-term assets | -4,726 | 11,468 | 11,511 | 3,813 |
| Accounts payable and other accrued liabilities | 2,545 | 5,013 | -19,434 | 8,191 |
| Accrued payroll and employee benefits | -30,724 | -1,842 | 17,385 | 111 |
| Insurance reserves | 3,743 | 2,815 | 4,285 | -4,929 |
| Operating lease liabilities | -4,925 | -4,728 | -5,044 | -9,479 |
| Other current and long-term liabilities | 3,871 | -9,898 | 2,623 | 1,745 |
| Net cash provided by (used in) operating activities | 4,349 | 49,720 | 33,200 | 42,937 |
| Acquisitions of businesses, net of cash acquired | - | 0 | 0 | 14,853 |
| Purchases of property and equipment, and software | 4,557 | 1,949 | 2,019 | 3,477 |
| Principal payments on financing lease obligations | - | 0 | 0 | 0 |
| Net cash used in investing activities | -4,557 | -1,949 | -2,019 | -18,330 |
| Proceeds from securitization obligation | - | 0 | 0 | 0 |
| Payments for shares withheld to cover employee taxes on vesting of restricted stock | 478 | 0 | 0 | 6,292 |
| Repayment of securitization obligation | - | 0 | 3,750 | 0 |
| Proceeds from exercise of options | 269 | 212 | - | - |
| Proceeds from issuance of term loans, net of debt issuance costs | - | 0 | 1,317,743 | - |
| Proceeds from employee stock purchase plan | 0 | 2,367 | 2,152 | 1,791 |
| Principal payments on term loans | 3,312 | 3,312 | 1,300,950 | 4,600 |
| Payment of debt issuance costs | - | 0 | 2,506 | 1,114 |
| Principal payments on notes payable | 2,406 | 3,037 | 1,768 | 4,086 |
| Settlements with interest rate swap counterparties | -2,149 | -3,393 | -3,026 | -6,144 |
| Net cash used in financing activities | -3,778 | -377 | 13,947 | -8,157 |
| Net change in cash and cash equivalents | -3,986 | 47,394 | 45,128 | 16,450 |
| Cash and cash equivalents at beginning of period | 193,260 | 145,866 | 84,288 | - |
| Cash and cash equivalents at end of period | 189,274 | 193,260 | 145,866 | - |
Aveanna Healthcare Holdings, Inc. (AVAH)
Aveanna Healthcare Holdings, Inc. (AVAH)